Skip to main content

IHV Awarded $50 Million to Combat HIV Crisis in Zambia

April 02, 2015

Robert Gallo

Grant comes as IHV reaches 1 million in HIV patient care overseas

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine received a $50 million five year grant from the President’s Emergency Plan for AIDS Relief (PEPFAR) to support the program, “Stop Mother and Child HIV Transmission” in Zambia. PEPFAR is a $48 billion initiative launched in 2004 by former President George W. Bush and continued by President Barack Obama. The announcement was made on the heels of IHV reaching the 1 million mark in care for HIV patients overseas.

 “This new funding will extend our reach and significantly grow the good work already being done by IHV’s Robert Sheneberger, MD and his team to combat HIV and AIDS in Zambia,” said Robert Gallo, MD, Director of the IHV, and most widely known for his co-discovery of HIV as the cause of AIDS and development of the HIV blood test. “We look forward to growing IHV’s effective education, diagnostic and treatment training models with the support of Zambia’s Ministry of Health.”

Through the $50 million five year grant, IHV will collaborate with the U.S. Centers for Disease Control to expand access and utilization of services for the Prevention of Mother to Child Transmission of HIV program, improve antiretroviral therapy coverage and effectiveness, enhance maternal child health services including the provision of better emergency obstetric and neonatal care, and lay the ground work for expanded community treatment of HIV within the Southern, Western, Eastern, and Lusaka provinces of Zambia.

“This grant funding creates the opportunity to demonstrate the impact of connecting every pregnant woman with a community worker to expand HIV testing into the community, promote early engagement in care, and improve retention ” said Dr. Sheneberger, the IHV principal investigator implementing the PEPFAR program in Zambia. “The targeted outcome is to eliminate transmission of HIV from mother to child, and improve maternal and infant survival.”

Under the direction of the IHV’s Division of Clinical Care and Research Director, Robert Redfield, MD, Dr. Sheneberger will lead a team of experts and personnel based in both Baltimore and Zambia to implement the new grant. The team will also include a small consortium of local and international partners including the Elizabeth Glaser Pediatric AIDS Foundation, the Futures Group, the Church Health Association of Zambia, and the Zambia Ministry of Community Development, Maternal and Child Health.

The IHV will build upon its current work in Zambia including the establishment of the country’s first post graduate training programs in HIV medicine and infectious diseases, as well as providing technical assistance to numerous facilities providing integrated HIV care and treatment services.

Since 2004, the IHV has received more than $300 million in PEPFAR grants enabling the Baltimore-based Institute to care for more than one million people infected with HIV, to reach nearly four million people with prevention interventions and HIV testing, and to train 35,000 health care professionals throughout PEPFAR’s target countries who have, in turn, delivered more than 100 million doses of medication.

About the Institute of Human Virology

Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland and the University of Maryland Medical System, IHV is an institute of the University of Maryland School of Medicine and is home to some of the most globally-recognized and world-renowned experts in all of virology. The IHV combines the disciplines of basic research, epidemiology and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably, HIV the virus that causes AIDS. For more information, visit www.ihv.org and follow us on Twitter @IHVmaryland.

 

 

Contact

Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559

Contact Media Relations
(410) 706-5260

Related stories

    Tuesday, December 04, 2018

    Institute of Human Virology Researchers Discover That a Bacterial Protein Promotes Cancer

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) announced today the discovery that DnaK, a protein of the bacterium mycoplasma, interferes with the mycoplasma-infected cell’s ability to respond to and repair DNA damage, a known origin of cancer.


    Wednesday, September 19, 2018

    Institute of Human Virology (IHV) Awarded $12M to Combat Opioid Epidemic Through Clinical Research Trials

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine will lead a $12 million dollar project to improve the morbidity and mortality of people with opioid use disorder (OUD). Utilizing a novel compound, IHV researches will implement a series of investigations, entitled SEARCH, to evaluate the underlying mechanisms of craving reduction as a strategy to prevent opioid misuse, dependence, and relapse. The grant is awarded through the National Institutes of Health’s (NIH) Helping to End Addiction Long-term (HEAL) Initiative, made possible through groundbreaking funding from the U.S. Congress.


    Wednesday, November 29, 2017

    To Mark World AIDS Day, Institute of Human Virology Releases Video on Dr. Robert Gallo

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) released a video on Dr. Robert Gallo, a trailblazer in HIV research, in advance of World AIDS Day, December 1. While many know Dr. Gallo for his pioneering work in AIDS research, the short video focuses on Dr. Gallo’s life and legacy in its entirety, including his pioneering discovery of human retroviruses.


    Tuesday, October 25, 2016

    "A Call to End HIV/AIDS in America" IHV Director Dr. Robert Gallo's Op-Ed in the Huffington Post

    As the new Administration is presented with great challenges facing the United States, one will be a longtime foe, the U.S. HIV/AIDS epidemic. Since President Barack Obama was elected in 2008, I have publicly called on our country’s leaders to utilize the largest global health initiative in history - the President’s Emergency Plan for AIDS Relief (PEPFAR) - as a model to address the U.S. epidemic.


    Monday, August 22, 2016

    Institute of Human Virology (IHV) Awarded $14.4M for HIV Vaccine Research

    The Institute of Human Virology (IHV) announced a $14.4M grant from NIAID to advance HIV vaccine research to solve a major challenge: produce long-lasting antibodies to protect against HIV infection.


    Thursday, March 10, 2016

    UM SOM Establishes Two Endowed Professorships Through Private Gifts and Matching State Funds

    University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that the School has been awarded matching funds from the Maryland Department of Business and Economic Development (DBED) as part of the Maryland E-Nnovation Initiative Fund program. The funds, when combined with private philanthropy, will enable UM SOM to establish two new endowed professorships – one in human virology and vaccine development, the other in surgical science and entrepreneurship.


    Tuesday, September 29, 2015

    Institute of Human Virology Hosts International Meeting of Prominent AIDS Researchers

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine is hosting IHV’s 17th Annual International Meeting Sunday, September 27 through Wednesday, September 30 at the Baltimore Marriott Waterfront Hotel in Baltimore, Maryland.


    Tuesday, June 23, 2015

    Institute of Human Virology (IHV) Awarded $24.5M to Fight Botswana’s AIDS Epidemic

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine has received a five-year $24.5 million grant from the U.S. Centers for Disease Control and Prevention (CDC) through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) to partner with the Government of Botswana and impact the HIV/AIDS epidemic in Botswana, and to demonstrate that comprehensive HIV/AIDS treatment programs can stop the epidemic. PEPFAR is a $48 billion initiative launched in 2004 by former President George W. Bush, and continued by President Barack Obama, to combat major infectious diseases around the world, including HIV.